Clincosm LogoSign in Get a demo

Rosacea

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Erythema, Rosacea Trial in United States (CD07805/47 gel 0.5%/CD07805/47 Vehicle, azelaic acid gel 15%)

Completed
Has Results
  • Erythema
  • Rosacea
  • CD07805/47 gel 0.5%/CD07805/47 Vehicle
  • azelaic acid gel 15%
  • Evansville, Indiana
  • +3 more
Jul 28, 2022

Rosacea Trial in United States (Doxycycline, Placebo)

Completed
Has Results
  • Rosacea
  • Hot Springs, Arkansas
  • +9 more
Jul 28, 2022

Rosacea Trial in Canada, United States (CD07805/47 gel, Placebo)

Completed
Has Results
  • Rosacea
  • CD07805/47 gel
  • Placebo
  • Los Angeles, California
  • +14 more
Feb 16, 2021

Inter- and Intra-rater Reliability of Clinician Erythema

Completed
Has Results
  • Erythema
  • Rosacea
  • No Intervention
  • Austin, Texas
    (unnamed)
Nov 15, 2019

Rosacea, Erythema Trial in Austin (AGN-199201 Dose A, AGN-199201 Dose B, AGN-199201 Dose C)

Completed
Has Results
  • Rosacea
  • Erythema
  • AGN-199201 Dose A
  • +3 more
  • Austin, Texas
    (unnamed)
Nov 15, 2019

Rosacea, Erythema Trial in Austin (AGN-199201 Formulation A, AGN-199201 Formulation B, AGN-199201 Formulation C)

Completed
Has Results
  • Rosacea
  • Erythema
  • AGN-199201 Formulation A
  • +3 more
  • Austin, Texas
    (unnamed)
Nov 15, 2019

Rosacea Trial in United States (DER 45 EV, Vehicle)

Completed
Has Results
  • Rosacea
  • Miami, Florida
  • +9 more
Dec 31, 2014

Rosacea Trial in United States (IDP-115, Vehicle)

Completed
  • Rosacea
  • Huntsville, Alabama
  • +9 more
Feb 16, 2012

Rosacea Trial in United States (Vehicle control, 2x/day, ACZONE (dapsone) Gel, 5%, 2x/day, ACZONE (dapsone) Gel, 5%, 1x/day)

Completed
  • Rosacea
  • Vehicle control, 2x/day
  • +4 more
  • Birmingham, Alabama
  • +25 more
May 27, 2011